Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TACSTD2 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
mRNA | PLAT | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | MPZL2 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-07 |
mRNA | ARL3 | CTRPv2 | pan-cancer | AAC | -0.2 | 8e-07 |
mRNA | CH17-296N19.1 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | FAM3C | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
mRNA | NIT2 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
mRNA | STK3 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
mRNA | GIPC1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
mRNA | SEMA3B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |